Intensive care unit-acquired Stenotrophomonas maltophilia:: incidence, risk factors, and outcome

被引:84
|
作者
Nseir, Saad
Di Pompeo, Christophe
Brisson, Helene
Dewavrin, Florent
Tissier, Stephanie
Diarra, Maimouna
Boulo, Marie
Durocher, Alain
机构
[1] Univ Hosp Lille, Calmette Hosp, Intens Care Unit, F-59037 Lille, France
[2] Univ Lille 2, Med Assessment Lab, F-59045 Lille, France
来源
CRITICAL CARE | 2006年 / 10卷 / 05期
关键词
D O I
10.1186/cc5063
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction The aim of this study was to determine incidence, risk factors, and impact on outcome of intensive care unit (ICU)acquired Stenotrophomonas maltophilia. Methods This prospective observational case-control study, which was a part of a cohort study, was conducted in a 30-bed ICU during a three year period. All immunocompetent patients hospitalised > 48 hours were eligible. Patients with non-fermenting Gram-negative bacilli (NF-GNB) at ICU admission were excluded. Patients without ICU-acquired S. maltophilia who developed an ICU-acquired NF-GNB other than S. maltophilia were also excluded. Screening ( tracheal aspirate and skin, anal, and nasal swabs) for NF-GNB was performed in all patients at ICU admission and weekly. Univariate and multivariate analyses were performed to determine risk factors for ICU-acquired S. maltophilia and for ICU mortality. Results Thirty-eight (2%) patients developed an S. maltophilia ICU-acquired colonisation and/or infection and were all successfully matched with 76 controls. Chronic obstructive pulmonary disease ( COPD) and duration of antibiotic treatment ( odds ratio [ OR] [ 95% confidence interval (CI)] = 9.4 [ 3 to 29], p < 0.001, and 1.4 [ 1 to 2.3], p = 0.001, respectively) were independently associated with ICU-acquired S. maltophilia. Mortality rate (60% versus 40%, OR [ 95% CI] = 1.3 [ 1 to 1.7, p = 0.037]), duration of mechanical ventilation ( 23 +/- 16 versus 7 +/- 11 days, p < 0.001), and duration of ICU stay ( 29 +/- 21 versus 15 +/- 17 days, p < 0.001) were significantly higher in cases than in controls. In addition, ICU-acquired infection related to S. maltophilia was independently associated with ICU mortality ( OR [ 95% CI] = 2.8 [ 1 to 7.7], p = 0.044). Conclusion COPD and duration of antibiotic treatment are independent risk factors for ICU-acquired S. maltophilia. ICU-acquired S. maltophilia is associated with increased morbidity and mortality rates. ICU-acquired infection related to S. maltophilia is an independent risk factor for ICU mortality.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Readmission to a surgical intensive care unit: incidence, outcome and risk factors
    Kaben, Axel
    Correa, Fabiano
    Reinhart, Konrad
    Settmacher, Utz
    Gummert, Jan
    Kalff, Rolf
    Sakr, Yasser
    CRITICAL CARE, 2008, 12 (05):
  • [42] Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study
    Guerci, Philippe
    Bellut, Hugo
    Mokhtari, Mokhtar
    Gaudefroy, Julie
    Mongardon, Nicolas
    Charpentier, Claire
    Louis, Guillaume
    Tashk, Parvine
    Dubost, Clement
    Ledochowski, Stanislas
    Kimmoun, Antoine
    Godet, Thomas
    Pottecher, Julien
    Lalot, Jean-Marc
    Novy, Emmanuel
    Hajage, David
    Bougle, Adrien
    CRITICAL CARE, 2019, 23 (01):
  • [43] Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study
    Philippe Guerci
    Hugo Bellut
    Mokhtar Mokhtari
    Julie Gaudefroy
    Nicolas Mongardon
    Claire Charpentier
    Guillaume Louis
    Parvine Tashk
    Clément Dubost
    Stanislas Ledochowski
    Antoine Kimmoun
    Thomas Godet
    Julien Pottecher
    Jean-Marc Lalot
    Emmanuel Novy
    David Hajage
    Adrien Bouglé
    Critical Care, 23
  • [44] Tracheostomy Management for Intensive Care Unit-acquired Weakness
    Johannes, Frauke
    Frohofer, Rahel
    SPRACHE-STIMME-GEHOR, 2025, 49 (01): : e1 - e6
  • [45] Molecular mechanisms of intensive care unit-acquired weakness
    Bloch, S.
    Polkey, M. I.
    Griffiths, M.
    Kemp, P.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 39 (04) : 1000 - 1011
  • [46] Intensive care unit-acquired weakness in the burn population
    Cubitt, Jonathan J.
    Davies, Menna
    Lye, George
    Evans, Janine
    Combellack, Tom
    Dickson, William
    Nguyen, Dai Q.
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2016, 69 (05): : E105 - E109
  • [47] Cost of intensive care unit-acquired bloodstream infections
    Laupland, K. B.
    Lee, H.
    Gregson, D. B.
    Manns, B. J.
    JOURNAL OF HOSPITAL INFECTION, 2006, 63 (02) : 124 - 132
  • [48] Population-based assessment of intensive care unit-acquired bloodstream infections in adults: Incidence, risk factors, and associated mortality rate
    Laupland, KB
    Zygun, DA
    Davies, HD
    Church, DL
    Louie, TJ
    Doig, CJ
    CRITICAL CARE MEDICINE, 2002, 30 (11) : 2462 - 2467
  • [49] Intensive Care Unit-Acquired Weakness: Introductory Notes
    de Carvalho, Mamede
    JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 2020, 37 (03) : 195 - 196
  • [50] Physiotherapy management of intensive care unit-acquired weakness
    Hodgson, Carol L.
    Tipping, Claire J.
    JOURNAL OF PHYSIOTHERAPY, 2017, 63 (01) : 4 - 10